134 related articles for article (PubMed ID: 2566673)
1. Neopterin: a predictive marker of acquired immune deficiency syndrome in human immunodeficiency virus infection.
Krämer A; Wiktor SZ; Fuchs D; Milstien S; Gail MH; Yellin FJ; Biggar RJ; Wachter H; Kaufman S; Blattner WA
J Acquir Immune Defic Syndr (1988); 1989; 2(3):291-6. PubMed ID: 2566673
[TBL] [Abstract][Full Text] [Related]
2. Immunologic markers of progression to acquired immunodeficiency syndrome are time-dependent and illness-specific.
Krämer A; Biggar RJ; Hampl H; Friedman RM; Fuchs D; Wachter H; Goedert JJ
Am J Epidemiol; 1992 Jul; 136(1):71-80. PubMed ID: 1384311
[TBL] [Abstract][Full Text] [Related]
3. [Neopterin--a prognostic marker in HIV infection].
Breustedt W; Rabe H; Volk D; Porstmann P
Dermatol Monatsschr; 1989; 175(4):226-31. PubMed ID: 2499491
[TBL] [Abstract][Full Text] [Related]
4. Urinary neopterin concentrations vs total neopterins for clinical utility.
Fuchs D; Milstien S; Krämer A; Reibnegger G; Werner ER; Goedert JJ; Kaufman S; Wachter H
Clin Chem; 1989 Dec; 35(12):2305-7. PubMed ID: 2591046
[TBL] [Abstract][Full Text] [Related]
5. Neopterin as a predictive marker for disease progression in human immunodeficiency virus type 1 infection.
Fuchs D; Spira TJ; Hausen A; Reibnegger G; Werner ER; Felmayer GW; Wachter H
Clin Chem; 1989 Aug; 35(8):1746-9. PubMed ID: 2635886
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
Fahey JL; Taylor JM; Detels R; Hofmann B; Melmed R; Nishanian P; Giorgi JV
N Engl J Med; 1990 Jan; 322(3):166-72. PubMed ID: 1967191
[TBL] [Abstract][Full Text] [Related]
7. Neopterin and human immunodeficiency virus infection.
Hofmann B
Eur J Clin Chem Clin Biochem; 1993 Apr; 31(4):191-5. PubMed ID: 8100453
[TBL] [Abstract][Full Text] [Related]
8. Virologic and serologic markers of rapid progression to AIDS after HIV-1 seroconversion.
Farzadegan H; Henrard DR; Kleeberger CA; Schrager L; Kirby AJ; Saah AJ; Rinaldo CR; O'Gorman M; Detels R; Taylor E; Phair JP; Margolick JB
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Dec; 13(5):448-55. PubMed ID: 8970472
[TBL] [Abstract][Full Text] [Related]
9. Immune activation markers and AIDS prognosis.
Osmond DH; Shiboski S; Bacchetti P; Winger EE; Moss AR
AIDS; 1991 May; 5(5):505-11. PubMed ID: 1677808
[TBL] [Abstract][Full Text] [Related]
10. Clinical and laboratory predictors of survival in Gambian patients with symptomatic HIV-1 or HIV-2 infection.
Whittle H; Egboga A; Todd J; Corrah T; Wilkins A; Demba E; Morgan G; Rolfe M; Berry N; Tedder R
AIDS; 1992 Jul; 6(7):685-9. PubMed ID: 1354448
[TBL] [Abstract][Full Text] [Related]
11. Neopterin and beta 2-microglobulin as prognostic indices in human immunodeficiency virus type 1 infection.
Fuchs D; Krämer A; Reibnegger G; Werner ER; Dierich MP; Goedert JJ; Wachter H
Infection; 1991; 19 Suppl 2():S98-102. PubMed ID: 1673120
[TBL] [Abstract][Full Text] [Related]
12. The initial immune response to HIV and immune system activation determine the outcome of HIV disease.
Sheppard HW; Ascher MS; McRae B; Anderson RE; Lang W; Allain JP
J Acquir Immune Defic Syndr (1988); 1991; 4(7):704-12. PubMed ID: 1675678
[TBL] [Abstract][Full Text] [Related]
13. Urinary neopterin concentrations and T-cell subset data in HIV-1 infection.
Reibnegger G; Fuchs D; Goedert JJ; Hausen A; Krämer A; Werner ER; Werner-Felmayer G; Dierich MP; Wachter H
Klin Wochenschr; 1990 Jan; 68(1):43-8. PubMed ID: 1968523
[TBL] [Abstract][Full Text] [Related]
14. Elevated urinary neopterin levels in patients with the acquired immunodeficiency syndrome (AIDS). A preliminary report.
Wachter H; Fuchs D; Hausen A; Huber C; Knosp O; Reibnegger G; Spira TJ
Hoppe Seylers Z Physiol Chem; 1983 Sep; 364(9):1345-6. PubMed ID: 6629341
[TBL] [Abstract][Full Text] [Related]
15. Tracking of markers and onset of disease among HIV-1 seroconverters.
Galai N; Muñoz A; Chen K; Carey VJ; Chmiel J; Zhou SY
Stat Med; 1993 Nov; 12(22):2133-45. PubMed ID: 7906051
[TBL] [Abstract][Full Text] [Related]
16. Neopterin as a marker in HIV infection.
Fuchs D; Hausen A; Reibnegger G; Werner ER; Dierich MP; Wachter H
Clin Chem; 1988 Feb; 34(2):466-7. PubMed ID: 3257724
[No Abstract] [Full Text] [Related]
17. Relationship and prognostic value of endogenous interferon-alpha, beta 2-microglobulin, and neopterin serum levels in patients with Kaposi sarcoma and AIDS.
Krown SE; Niedzwiecki D; Bhalla RB; Flomenberg N; Bundow D; Chapman D
J Acquir Immune Defic Syndr (1988); 1991; 4(9):871-80. PubMed ID: 1895208
[TBL] [Abstract][Full Text] [Related]
18. [Study on serum neopterin concentration in hemophiliacs with anti-human immunodeficiency-virus type I antibody].
Matsuda J
Rinsho Byori; 1991 Jul; 39(7):743-7. PubMed ID: 1920867
[TBL] [Abstract][Full Text] [Related]
19. Serum neopterin changes in HIV-infected subjects: indicator of significant pathology, CD4 T cell changes, and the development of AIDS.
Melmed RN; Taylor JM; Detels R; Bozorgmehri M; Fahey JL
J Acquir Immune Defic Syndr (1988); 1989; 2(1):70-6. PubMed ID: 2783972
[TBL] [Abstract][Full Text] [Related]
20. Replacing time since human immunodeficiency virus infection by marker values in predicting residual time to acquired immunodeficiency syndrome diagnosis. Multicenter AIDS Cohort Study.
Shi M; Taylor JM; Currier RJ; Tang H; Hoover DR; Chmiel JS; Bryant JL
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jul; 12(3):309-16. PubMed ID: 8673537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
